Triple, dual and single incretin receptor agonists alongside the wider metabolic set — NNMT inhibitors, mitochondrial uncouplers and fatty-acid transport compounds.
Join the Peps Depot mailing list for high-demand restock alerts, subscriber-only offers, release updates and priority access — plus The Friday Brief, our weekly peptide research newsletter covering what actually moved that week. New compounds, new trial data, regulatory shifts.